Novavax Inc vs Tidewater Inc — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Tidewater Inc trades at $78.18 (market cap $3.75B). The key difference: Tidewater Inc is far larger — about 2.9× Novavax Inc's market cap, and Tidewater Inc is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | TDW | |
|---|---|---|
Market Cap | $1.30B | $3.75B |
Sector | Health | Utilities |
52-Week High | $11.19 | $91.12 |
52-Week Low | $6.22 | $47.29 |
Enterprise Value | $800.50M | $3.85B |
Trailing returns across standard periods
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →Tidewater is the leading global provider of offshore support vessels (OSVs) to the energy industry. With the world's largest fleet of platform supply vessels (PSVs) and anchor handling tugs (AHTS), it provides critical logistics and marine support for offshore oil, gas, and renewable energy projects. Following a period of massive strategic consolidation, Tidewater is now focused on maximizing day rates and free cash flow in a supply-constrained market, positioning itself as a primary beneficiary of the multi-year offshore upcycle.
Read more on TDW →